Response shift due to diagnosis and primary treatment of localized prostate cancer: A then-test and a vignette study

Quality of Life Research

Volumn 16, Issue 10, 2007, Pages 1627-1634

  Korfage, Ida J ^a   De Koning, Harry J ^a   Essink Bot, Marie Louise ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Patient reported outcome; Prostate cancer; Quality of life; Response shift

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SCREENING; CONTROLLED STUDY; ENTEROPATHY; ERECTILE DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT ASSESSMENT; PRETEST POSTTEST DESIGN; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF CONCEPT; SHORT FORM 36; URINARY TRACT; VIGNETTE;

AGED; ATTITUDE TO HEALTH; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SELF DISCLOSURE; TREATMENT OUTCOME;

EID: 35848953628     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-007-9265-6     Document Type: Article

References (20)

1. Schwartz, C., & Sprangers, M. (2000). Adaptation to changing health: Response shift in quality-of-life research. Washington, DC: American Psychological Association.
2. Visser, M. R., Oort, F. J., & Sprangers, M. A. (2005). Methods to detect response shift in quality of life data: A convergent validity study. Quality of Life Research, 14(3), 629-639.
3. Schwartz, C. E., & Sprangers, M. A. (1999). Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Social Science & Medicine, 48(11), 1531-1548.
4. Sprangers, M. A., & Schwartz, C. E. (1999). Integrating response shift into health-related quality of life research: a theoretical model. Social Science & Medicine, 48(11), 1507-1515.
5. Schwartz, C. E., Bode, R., Repucci, N., Becker, J., Sprangers, M. A., & Fayers, P. M. (2006). The clinical significance of adaptation to changing health: A meta-analysis of response shift. Quality of Life Research, 15(9), 1533-1550.
6. Cohen, J. (1977). Statistical power analysis for the behavioral sciences. New York: Academic Press.
7. Sprangers, M. A., Moinpour, C. M., Moynihan, T. J., Patrick, D. L., & Revicki, D. A. (2002). Assessing meaningful change in quality of life over time: A users' guide for clinicians. Mayo Clinic Proceedings, 77(6), 561-571.
8. Korfage, I. J., de Koning, H. J., Roobol, M., Schroder, F. H., & Essink-Bot, M. L. (2006). Prostate cancer diagnosis: The impact on patients' mental health. European Journal of Cancer, 42(2), 165-170.
9. Roobol, M. J., Kirkels, W. J., Schroder, F. H. (2003). Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands). BJU International, 92(Suppl 2), 48-54.
10. Ware, J. E., & Kosinski, M. (2001). Interpreting SF-36 summary health measures: A response. Quality of Life Research, 10(5), 405-413 discussion 15-20.
11. Brooks, R. (1996). EuroQol: The current state of play. Health Policy, 37(1), 53-72.
12. Ware, J. E. J., Snow, K. K., Kosinski, M., & Gandek, B. G. (1993). SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center.
13. Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582-592.
14. Norman, G. (2003). Hi! How are you? Response shift, implicit theories and differing epistemologies. Quality of Life Research, 12(3), 239-249.
15. Kramer, K. M., Bennett, C. L., Pickard, A. S., Lyons, E. A., Wolf, M. S., McKoy, J. M., et al. (2005). Patient preferences in prostate cancer: A clinician's guide to understanding health utilities. Clinical Prostate Cancer, 4(1), 15-23.
16. Cowen, M. E., Miles, B. J., Cahill, D. F., Giesler, R. B., Beck, J. R., & Kattan, M. W. (1998). The danger of applying group-level utilities in decision analyses of the treatment of localized prostate cancer in individual patients. Medical Decision Making, 18(4), 376-380.
17. Rees, J, Waldron, D., O'Boyle, C., Ewings, P., & MacDonagh, R. (2003). Prospective vs retrospective assessment of lower urinary tract symptoms in patients with advanced prostate cancer: the effect of 'response shift'. BJU International, 92(7), 703-706.
18. Rees, J., Clarke, M. G., Waldron, D., O'Boyle, C., Ewings, P., & MacDonagh, R. P. (2005). The measurement of response shift in patients with advanced prostate cancer and their partners. Health Qual Life Outcomes, 3, 21.
19. Lepore, S. J., & Eton, D. T. (2000). Response shifts in prostate cancer patients: an evaluation of suppressor and buffer models. In C. E. Schwartz & M. A. G. Sprangers (Eds.), Adaptation to changing health, response shift in quality-of-life research. Washington DC.
20. Korfage, I. J., Hak, T., de Koning, H. J., & Essink-Bot, M. L. (2006). Patients' perceptions of the side-effects of prostate cancer treatment-a qualitative interview study. Social Science & Medicine, 63(4), 911-919.